| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | histone binding | 5.38e-05 | 265 | 128 | 9 | GO:0042393 | |
| GeneOntologyMolecularFunction | chromatin binding | ATRX NOC2L CHD2 SSRP1 PAF1 JMJD1C SFMBT2 KAT7 TNRC18 SBNO1 KMT5B PKNOX1 ASXL2 RERE BAHCC1 | 7.92e-05 | 739 | 128 | 15 | GO:0003682 |
| GeneOntologyBiologicalProcess | chromatin organization | SETD1A ZMYND11 ATRX BAZ2B NOC2L CHD2 HUWE1 SSRP1 JMJD1C KAT7 SETD2 KANSL1 BRDT UBR5 KMT5B CFDP1 ERCC6L2 PHF14 RERE BAHCC1 | 5.04e-07 | 896 | 126 | 20 | GO:0006325 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | SETD1A ZMYND11 ATRX BAZ2B NOC2L CHD2 HUWE1 SSRP1 JMJD1C KAT7 SETD2 KANSL1 BRDT UBR5 KMT5B TRAPPC12 CFDP1 ERCC6L2 PHF14 RERE BAHCC1 | 6.71e-07 | 999 | 126 | 21 | GO:0071824 |
| GeneOntologyBiologicalProcess | chromatin remodeling | SETD1A ATRX BAZ2B NOC2L CHD2 HUWE1 SSRP1 JMJD1C KAT7 SETD2 BRDT UBR5 KMT5B CFDP1 ERCC6L2 RERE | 1.18e-05 | 741 | 126 | 16 | GO:0006338 |
| GeneOntologyCellularComponent | chromatin | SOX4 HMBOX1 SETD1A ATRX BAZ2B NOC2L DVL3 CHD2 SSRP1 WDR76 JMJD1C ORC2 KAT7 KANSL1 BRDT UBR5 CFDP1 NFXL1 PKNOX1 TMPO PHF14 PROX1 | 8.97e-05 | 1480 | 128 | 22 | GO:0000785 |
| HumanPheno | Aggressive behavior | SOX4 SETD1A ZMYND11 FRMPD4 ATRX CHD2 ODC1 SHQ1 PACS1 SETD2 PTCHD1 KANSL1 KMT5B FIG4 SCN3A AP3B2 RERE ATP1A2 | 2.61e-07 | 516 | 47 | 18 | HP:0000718 |
| HumanPheno | Abnormal aggressive, impulsive or violent behavior | SOX4 SETD1A ZMYND11 FRMPD4 ATRX CHD2 ODC1 SHQ1 PACS1 SETD2 PTCHD1 KANSL1 KMT5B FIG4 SCN3A AP3B2 RERE ATP1A2 | 2.61e-07 | 516 | 47 | 18 | HP:0006919 |
| HumanPheno | High forehead | SETD1A FRMPD4 DVL1 DVL3 ODC1 HUWE1 SETD2 KANSL1 KMT5B FIG4 SCN3A AP3B2 ATP1A2 | 2.26e-06 | 306 | 47 | 13 | HP:0000348 |
| HumanPheno | Disinhibition | SOX4 FLG SETD1A ZMYND11 FRMPD4 ATRX CHD2 ODC1 HUWE1 JMJD1C SHQ1 PACS1 SETD2 PTCHD1 KANSL1 KMT5B FIG4 SCN3A AP3B2 RERE ATP1A2 | 2.49e-06 | 807 | 47 | 21 | HP:0000734 |
| HumanPheno | Inappropriate behavior | SOX4 FLG SETD1A ZMYND11 FRMPD4 ATRX CHD2 ODC1 HUWE1 JMJD1C SHQ1 PACS1 SETD2 PTCHD1 KANSL1 KMT5B FIG4 SCN3A AP3B2 RERE ATP1A2 | 2.49e-06 | 807 | 47 | 21 | HP:0000719 |
| HumanPheno | Abnormal response to social norms | SOX4 FLG SETD1A ZMYND11 FRMPD4 ATRX CHD2 ODC1 HUWE1 JMJD1C SHQ1 PACS1 SETD2 PTCHD1 KANSL1 KMT5B FIG4 SCN3A AP3B2 RERE ATP1A2 | 2.49e-06 | 807 | 47 | 21 | HP:5200123 |
| HumanPheno | Social disinhibition | SOX4 FLG SETD1A ZMYND11 FRMPD4 ATRX CHD2 ODC1 HUWE1 JMJD1C SHQ1 PACS1 SETD2 PTCHD1 KANSL1 KMT5B FIG4 SCN3A AP3B2 RERE ATP1A2 | 2.49e-06 | 807 | 47 | 21 | HP:5200029 |
| HumanPheno | Abnormal social development | SOX4 FLG SETD1A ZMYND11 FRMPD4 ATRX CHD2 ODC1 HUWE1 JMJD1C SHQ1 PACS1 SETD2 PTCHD1 KANSL1 KMT5B FIG4 SCN3A AP3B2 RERE ATP1A2 AGTPBP1 | 4.20e-06 | 908 | 47 | 22 | HP:0025732 |
| HumanPheno | Abnormally increased volition | SOX4 FLG SETD1A ZMYND11 FRMPD4 ATRX CHD2 ODC1 HUWE1 JMJD1C SHQ1 PACS1 SETD2 PTCHD1 KANSL1 KMT5B FIG4 SCN3A AP3B2 RERE ATP1A2 | 8.44e-06 | 869 | 47 | 21 | HP:5200263 |
| HumanPheno | Abnormality of the palpebral fissures | SETD1A ZMYND11 ATRX DVL1 DVL3 ODC1 HUWE1 JMJD1C PACS1 DACT1 SETD2 TRMT10A KANSL1 FIG4 CCDC47 PPP1R15B SCN3A AP3B2 RERE DBR1 ATP1A2 | 1.03e-05 | 880 | 47 | 21 | HP:0008050 |
| HumanPheno | Slanting of the palpebral fissure | SETD1A ZMYND11 ATRX DVL1 DVL3 ODC1 HUWE1 JMJD1C PACS1 SETD2 TRMT10A KANSL1 FIG4 PPP1R15B SCN3A AP3B2 RERE DBR1 ATP1A2 | 1.18e-05 | 739 | 47 | 19 | HP:0200006 |
| HumanPheno | Autistic behavior | SOX4 FLG SETD1A FRMPD4 ATRX CHD2 JMJD1C PACS1 SETD2 PTCHD1 KANSL1 KMT5B SBF2 SCN3A AP3B2 RERE ATP1A2 AGTPBP1 | 1.44e-05 | 678 | 47 | 18 | HP:0000729 |
| HumanPheno | Abnormality of mouth size | SOX4 SETD1A ZMYND11 ATRX DVL1 CHD2 HUWE1 JMJD1C PACS1 DACT1 TRMT10A CCDC47 PPP1R15B RERE | 1.68e-05 | 425 | 47 | 14 | HP:0011337 |
| HumanPheno | Downslanted palpebral fissures | SETD1A DVL1 DVL3 ODC1 HUWE1 JMJD1C PACS1 SETD2 TRMT10A PPP1R15B SCN3A AP3B2 RERE DBR1 ATP1A2 | 2.20e-05 | 497 | 47 | 15 | HP:0000494 |
| HumanPheno | Absent speech | SOX4 FRMPD4 ODC1 HUWE1 SHQ1 PACS1 KMT5B CCDC47 SCN3A AP3B2 RERE ATP1A2 EIF2AK2 AGTPBP1 | 2.25e-05 | 436 | 47 | 14 | HP:0001344 |
| HumanPheno | Macrostomia | 2.34e-05 | 220 | 47 | 10 | HP:0000181 | |
| HumanPheno | Wide mouth | 2.34e-05 | 220 | 47 | 10 | HP:0000154 | |
| HumanPheno | Cupped ear | 3.44e-05 | 69 | 47 | 6 | HP:0000378 | |
| HumanPheno | Deficiency of speech development | SOX4 FRMPD4 ODC1 HUWE1 SHQ1 PACS1 KMT5B CCDC47 SCN3A AP3B2 RERE ATP1A2 EIF2AK2 AGTPBP1 | 4.43e-05 | 463 | 47 | 14 | HP:0002116 |
| HumanPheno | Diagnostic behavioral phenotype | SOX4 FLG SETD1A FRMPD4 ATRX CHD2 JMJD1C PACS1 SETD2 PTCHD1 KANSL1 KMT5B SBF2 SCN3A AP3B2 RERE ATP1A2 AGTPBP1 | 5.53e-05 | 747 | 47 | 18 | HP:0025783 |
| HumanPheno | Abnormal external nose morphology | SOX4 SETD1A FRMPD4 ATRX DVL1 DVL3 CHD2 ODC1 HUWE1 JMJD1C PACS1 SETD2 TRMT10A KANSL1 KMT5B FIG4 CCDC47 PPP1R15B ASXL2 RERE | 7.30e-05 | 916 | 47 | 20 | HP:0010938 |
| HumanPheno | Hyperactivity | SOX4 FLG FRMPD4 ATRX CHD2 ODC1 HUWE1 JMJD1C PTCHD1 KANSL1 KMT5B SCN3A AP3B2 RERE ATP1A2 | 8.63e-05 | 558 | 47 | 15 | HP:0000752 |
| HumanPheno | Reduced impulse control | SOX4 FLG SETD1A ZMYND11 FRMPD4 ATRX CHD2 ODC1 HUWE1 JMJD1C SHQ1 PACS1 SETD2 PTCHD1 KANSL1 KMT5B FIG4 SCN3A AP3B2 RERE ATP1A2 | 1.25e-04 | 1032 | 47 | 21 | HP:5200045 |
| HumanPheno | Abnormality of the forehead | SOX4 SETD1A FRMPD4 ATRX DVL1 DVL3 CHD2 ODC1 HUWE1 BRWD3 PACS1 SETD2 TRMT10A KANSL1 KMT5B FIG4 CCDC47 PPP1R15B SCN3A AP3B2 ASXL2 RERE ATP1A2 | 1.36e-04 | 1208 | 47 | 23 | HP:0000290 |
| HumanPheno | Abnormal nasal tip morphology | SOX4 FRMPD4 ATRX ODC1 HUWE1 JMJD1C PACS1 SETD2 KANSL1 CCDC47 ASXL2 RERE | 1.38e-04 | 386 | 47 | 12 | HP:0000436 |
| HumanPheno | Delayed speech and language development | SOX4 SETD1A ZMYND11 FRMPD4 CHD2 ODC1 HUWE1 BRWD3 SHQ1 PACS1 SETD2 KANSL1 KMT5B FIG4 CCDC47 SCN3A AP3B2 ASXL2 RERE ATP1A2 EIF2AK2 AGTPBP1 | 1.38e-04 | 1123 | 47 | 22 | HP:0000750 |
| HumanPheno | Abnormal eyelid morphology | SOX4 SETD1A ZMYND11 ATRX DVL1 DVL3 ODC1 HUWE1 JMJD1C PACS1 DACT1 SETD2 TRMT10A KANSL1 KMT5B FIG4 CCDC47 PPP1R15B SCN3A AP3B2 ASXL2 RERE DBR1 ATP1A2 MLPH | 1.78e-04 | 1408 | 47 | 25 | HP:0000492 |
| HumanPheno | Thin upper lip vermilion | SOX4 ATRX DVL1 CHD2 ODC1 HUWE1 PACS1 TRMT10A FIG4 PPP1R15B ASXL2 | 1.91e-04 | 339 | 47 | 11 | HP:0000219 |
| HumanPheno | Thin lips | SOX4 ATRX DVL1 CHD2 ODC1 HUWE1 PACS1 TRMT10A FIG4 PPP1R15B ASXL2 | 1.91e-04 | 339 | 47 | 11 | HP:0000213 |
| HumanPheno | Abnormality of upper lip vermillion | SOX4 SETD1A ATRX DVL1 CHD2 ODC1 HUWE1 PACS1 TRMT10A FIG4 PPP1R15B ASXL2 ATP1A2 | 1.96e-04 | 464 | 47 | 13 | HP:0011339 |
| HumanPheno | Abnormal eyelash morphology | 2.03e-04 | 284 | 47 | 10 | HP:0000499 | |
| HumanPheno | Abnormality of globe location or size | SETD1A ZMYND11 ATRX DVL1 DVL3 CHD2 ODC1 HUWE1 JMJD1C PACS1 DACT1 SETD2 TRMT10A KANSL1 FIG4 CCDC47 PPP1R15B SBF2 AP3B2 CTDP1 ASXL2 RERE DBR1 | 2.25e-04 | 1246 | 47 | 23 | HP:0000489 |
| HumanPheno | Ptosis | SOX4 ZMYND11 ATRX DVL1 DVL3 ODC1 HUWE1 JMJD1C PACS1 KANSL1 CCDC47 SBF2 SCN3A AP3B2 ASXL2 RERE ATP1A2 | 2.27e-04 | 754 | 47 | 17 | HP:0000508 |
| HumanPheno | Large clumps of pigment irregularly distributed along hair shaft | 2.49e-04 | 3 | 47 | 2 | HP:0004527 | |
| HumanPheno | Epicanthus | SOX4 SETD1A ATRX DVL1 DVL3 HUWE1 JMJD1C TRMT10A KANSL1 KMT5B FIG4 CCDC47 PPP1R15B ASXL2 RERE | 2.56e-04 | 614 | 47 | 15 | HP:0000286 |
| HumanPheno | Language impairment | SOX4 SETD1A ZMYND11 FRMPD4 CHD2 ODC1 HUWE1 BRWD3 SHQ1 PACS1 SETD2 KANSL1 KMT5B FIG4 CCDC47 SCN3A AP3B2 ASXL2 RERE ATP1A2 EIF2AK2 AGTPBP1 | 2.89e-04 | 1178 | 47 | 22 | HP:0002463 |
| HumanPheno | Oligodontia | 2.94e-04 | 65 | 47 | 5 | HP:0000677 | |
| HumanPheno | Abnormal corpus callosum morphology | SOX4 FRMPD4 ATRX ODC1 HUWE1 DACT1 SETD2 TRMT10A KANSL1 FIG4 TRAPPC12 CCDC47 PPP1R15B SCN3A AP3B2 RERE ATP1A2 EIF2AK2 AGTPBP1 | 3.38e-04 | 937 | 47 | 19 | HP:0001273 |
| HumanPheno | Abnormal cerebral white matter morphology | SOX4 FRMPD4 ATRX ODC1 HUWE1 DACT1 SETD2 TRMT10A KANSL1 FIG4 TRAPPC12 CCDC47 PPP1R15B SCN3A AP3B2 CTDP1 ASXL2 RERE ATP1A2 EIF2AK2 AGTPBP1 | 3.87e-04 | 1114 | 47 | 21 | HP:0002500 |
| HumanPheno | Thin corpus callosum | SOX4 FRMPD4 ATRX HUWE1 DACT1 SETD2 TRMT10A KANSL1 FIG4 TRAPPC12 CCDC47 PPP1R15B SCN3A AP3B2 RERE ATP1A2 EIF2AK2 AGTPBP1 | 3.99e-04 | 868 | 47 | 18 | HP:0033725 |
| HumanPheno | Appendicular spasticity | SOX4 ATRX ODC1 HUWE1 LYST SHQ1 TRMT10A FIG4 TRAPPC12 PPP1R15B SCN3A RERE | 4.24e-04 | 435 | 47 | 12 | HP:0034353 |
| HumanPheno | Dorsocervical fat pad | 4.57e-04 | 17 | 47 | 3 | HP:0025383 | |
| HumanPheno | Tapered toe | 4.94e-04 | 4 | 47 | 2 | HP:0011309 | |
| HumanPheno | Melanin pigment aggregation in hair shafts | 4.94e-04 | 4 | 47 | 2 | HP:0002220 | |
| HumanPheno | Dilation of Virchow-Robin spaces | 5.45e-04 | 18 | 47 | 3 | HP:0012520 | |
| HumanPheno | Impairment in personality functioning | SOX4 FLG SETD1A ZMYND11 FRMPD4 ATRX CHD2 ODC1 HUWE1 JMJD1C SHQ1 PACS1 SETD2 PTCHD1 KANSL1 KMT5B FIG4 SCN3A AP3B2 RERE ATP1A2 | 5.46e-04 | 1141 | 47 | 21 | HP:0031466 |
| HumanPheno | Autism | 5.64e-04 | 264 | 47 | 9 | HP:0000717 | |
| HumanPheno | Abnormal hair morphology | SOX4 ZMYND11 FRMPD4 ATRX DVL1 DVL3 CHD2 ODC1 HUWE1 LYST JMJD1C PACS1 SETD2 TRMT10A KANSL1 KMT5B FIG4 CCDC47 PPP1R15B AP3B2 ASXL2 RERE ATP1A2 MLPH | 6.39e-04 | 1424 | 47 | 24 | HP:0001595 |
| HumanPheno | Upslanted palpebral fissure | 7.30e-04 | 333 | 47 | 10 | HP:0000582 | |
| HumanPheno | Reduced social responsiveness | 8.30e-04 | 170 | 47 | 7 | HP:0012760 | |
| HumanPheno | Overfolded helix | 8.63e-04 | 82 | 47 | 5 | HP:0000396 | |
| HumanPheno | Attention deficit hyperactivity disorder | FLG CHD2 ODC1 JMJD1C PTCHD1 KANSL1 KMT5B SCN3A AP3B2 RERE ATP1A2 | 1.04e-03 | 413 | 47 | 11 | HP:0007018 |
| HumanPheno | Impaired social interactions | 1.08e-03 | 129 | 47 | 6 | HP:0000735 | |
| HumanPheno | Long eyelashes | 1.08e-03 | 129 | 47 | 6 | HP:0000527 | |
| HumanPheno | Cryptorchidism | SOX4 FLG ATRX DVL1 DVL3 ODC1 HUWE1 JMJD1C BRWD3 PACS1 DACT1 KANSL1 KMT5B FIG4 PPP1R15B RERE | 1.10e-03 | 780 | 47 | 16 | HP:0000028 |
| HumanPheno | Abnormality of the dentition | SOX4 SETD1A ATRX DVL1 DVL3 HUWE1 LYST JMJD1C PACS1 TRMT10A KANSL1 FIG4 CCDC47 PPP1R15B SCN3A AP3B2 CTDP1 RERE ATP1A2 | 1.16e-03 | 1030 | 47 | 19 | HP:0000164 |
| HumanPheno | Demyelination | 1.19e-03 | 88 | 47 | 5 | HP:0003381 | |
| HumanPheno | Abnormal cerebral subcortex morphology | SOX4 FRMPD4 ATRX ODC1 HUWE1 DACT1 SETD2 TRMT10A KANSL1 FIG4 TRAPPC12 CCDC47 PPP1R15B SCN3A AP3B2 CTDP1 ASXL2 RERE ATP1A2 EIF2AK2 AGTPBP1 | 1.20e-03 | 1207 | 47 | 21 | HP:0010993 |
| HumanPheno | Anteverted nares | SOX4 SETD1A ATRX DVL1 DVL3 CHD2 HUWE1 SETD2 TRMT10A FIG4 PPP1R15B ASXL2 RERE | 1.20e-03 | 559 | 47 | 13 | HP:0000463 |
| HumanPheno | Upturned nose | SOX4 SETD1A ATRX DVL1 DVL3 CHD2 HUWE1 SETD2 TRMT10A FIG4 PPP1R15B ASXL2 RERE | 1.20e-03 | 559 | 47 | 13 | HP:0000427 |
| HumanPheno | Slender toe | 1.22e-03 | 6 | 47 | 2 | HP:0011308 | |
| HumanPheno | Silver-gray hair | 1.22e-03 | 6 | 47 | 2 | HP:0002218 | |
| HumanPheno | Abnormality of mouth shape | 1.22e-03 | 294 | 47 | 9 | HP:0011338 | |
| HumanPheno | Downturned corners of mouth | 1.24e-03 | 182 | 47 | 7 | HP:0002714 | |
| HumanPheno | Macrocephaly | SETD1A DVL1 DVL3 ODC1 HUWE1 BRWD3 SETD2 KANSL1 KMT5B FIG4 ASXL2 RERE | 1.26e-03 | 491 | 47 | 12 | HP:0000256 |
| HumanPheno | Abnormality of the helix | 1.28e-03 | 183 | 47 | 7 | HP:0000380 | |
| HumanPheno | Broad thumb | 1.32e-03 | 90 | 47 | 5 | HP:0011304 | |
| HumanPheno | Abnormally folded helix | 1.32e-03 | 90 | 47 | 5 | HP:0008544 | |
| HumanPheno | Abnormal morphology of the nasal alae | SOX4 SETD1A ATRX DVL1 DVL3 CHD2 HUWE1 SETD2 TRMT10A KANSL1 FIG4 PPP1R15B ASXL2 RERE | 1.33e-03 | 639 | 47 | 14 | HP:0000429 |
| HumanPheno | Abnormal size of the palpebral fissures | 1.35e-03 | 298 | 47 | 9 | HP:0200007 | |
| HumanPheno | Abnormal testis morphology | SOX4 FLG SETD1A ATRX DVL1 DVL3 PCARE ODC1 HUWE1 JMJD1C BRWD3 PACS1 DACT1 KANSL1 KMT5B FIG4 PPP1R15B CTDP1 RERE ATP1A2 | 1.35e-03 | 1129 | 47 | 20 | HP:0000035 |
| Domain | ZF_PHD_2 | 4.47e-06 | 95 | 130 | 7 | PS50016 | |
| Domain | ZF_PHD_1 | 4.80e-06 | 96 | 130 | 7 | PS01359 | |
| Domain | BAH | 5.22e-05 | 11 | 130 | 3 | PS51038 | |
| Domain | BAH_dom | 5.22e-05 | 11 | 130 | 3 | IPR001025 | |
| Domain | BAH | 5.22e-05 | 11 | 130 | 3 | SM00439 | |
| Domain | BAH | 5.22e-05 | 11 | 130 | 3 | PF01426 | |
| Domain | Oxysterol-bd_CS | 6.92e-05 | 12 | 130 | 3 | IPR018494 | |
| Domain | Oxysterol_BP | 6.92e-05 | 12 | 130 | 3 | PF01237 | |
| Domain | Oxysterol-bd | 6.92e-05 | 12 | 130 | 3 | IPR000648 | |
| Domain | OSBP | 6.92e-05 | 12 | 130 | 3 | PS01013 | |
| Domain | Znf_FYVE_PHD | 7.64e-05 | 147 | 130 | 7 | IPR011011 | |
| Domain | Bromodomain | 1.38e-04 | 38 | 130 | 4 | PF00439 | |
| Domain | Dishevelled_C-dom | 1.44e-04 | 3 | 130 | 2 | IPR024580 | |
| Domain | SBF2 | 1.44e-04 | 3 | 130 | 2 | PF12335 | |
| Domain | Dsh_C | 1.44e-04 | 3 | 130 | 2 | PF12316 | |
| Domain | SBF1/SBF2 | 1.44e-04 | 3 | 130 | 2 | IPR022096 | |
| Domain | PHD | 1.77e-04 | 75 | 130 | 5 | PF00628 | |
| Domain | BROMODOMAIN_2 | 1.86e-04 | 41 | 130 | 4 | PS50014 | |
| Domain | Bromodomain | 2.04e-04 | 42 | 130 | 4 | IPR001487 | |
| Domain | BROMO | 2.04e-04 | 42 | 130 | 4 | SM00297 | |
| Domain | - | 2.04e-04 | 42 | 130 | 4 | 1.20.920.10 | |
| Domain | Znf_PHD-finger | 2.26e-04 | 79 | 130 | 5 | IPR019787 | |
| Domain | IQ | 2.54e-04 | 81 | 130 | 5 | SM00015 | |
| Domain | Dishevelled | 2.86e-04 | 4 | 130 | 2 | PF02377 | |
| Domain | Dsh/Dvl-rel | 2.86e-04 | 4 | 130 | 2 | IPR015506 | |
| Domain | Dishevelled_fam | 2.86e-04 | 4 | 130 | 2 | IPR008339 | |
| Domain | Dishevelled_protein_dom | 2.86e-04 | 4 | 130 | 2 | IPR003351 | |
| Domain | PHD | 3.93e-04 | 89 | 130 | 5 | SM00249 | |
| Domain | IQ_motif_EF-hand-BS | 4.14e-04 | 90 | 130 | 5 | IPR000048 | |
| Domain | Znf_PHD | 4.36e-04 | 91 | 130 | 5 | IPR001965 | |
| Domain | IQ | 4.82e-04 | 93 | 130 | 5 | PS50096 | |
| Domain | Na_trans_cytopl | 7.08e-04 | 6 | 130 | 2 | PF11933 | |
| Domain | Na_trans_cytopl | 7.08e-04 | 6 | 130 | 2 | IPR024583 | |
| Domain | PH_dom-like | FRMPD4 MYO10 SSRP1 EPB41L3 LYST ARHGEF10L SBF2 OSBPL7 PHLPP1 OSBP2 | 8.02e-04 | 426 | 130 | 10 | IPR011993 |
| Domain | RPEL | 9.87e-04 | 7 | 130 | 2 | PS51073 | |
| Domain | RPEL | 9.87e-04 | 7 | 130 | 2 | SM00707 | |
| Domain | RPEL | 9.87e-04 | 7 | 130 | 2 | PF02755 | |
| Domain | DIX | 9.87e-04 | 7 | 130 | 2 | PF00778 | |
| Domain | RPEL_repeat | 9.87e-04 | 7 | 130 | 2 | IPR004018 | |
| Domain | DIX | 9.87e-04 | 7 | 130 | 2 | IPR001158 | |
| Domain | DIX | 9.87e-04 | 7 | 130 | 2 | PS50841 | |
| Domain | DAX | 9.87e-04 | 7 | 130 | 2 | SM00021 | |
| Domain | Zinc_finger_PHD-type_CS | 1.09e-03 | 65 | 130 | 4 | IPR019786 | |
| Domain | WD40_repeat_dom | 1.13e-03 | 297 | 130 | 8 | IPR017986 | |
| Domain | SNF2_N | 1.41e-03 | 32 | 130 | 3 | IPR000330 | |
| Domain | SNF2_N | 1.41e-03 | 32 | 130 | 3 | PF00176 | |
| Domain | IQ | 1.52e-03 | 71 | 130 | 4 | PF00612 | |
| Domain | Ubiquitin-rel_dom | 1.83e-03 | 184 | 130 | 6 | IPR029071 | |
| Domain | Na_channel_asu | 2.09e-03 | 10 | 130 | 2 | IPR001696 | |
| Domain | Na_trans_assoc | 2.09e-03 | 10 | 130 | 2 | IPR010526 | |
| Domain | Na_trans_assoc | 2.09e-03 | 10 | 130 | 2 | PF06512 | |
| Domain | BROMODOMAIN_1 | 2.15e-03 | 37 | 130 | 3 | PS00633 | |
| Domain | WD40 | 2.26e-03 | 259 | 130 | 7 | PF00400 | |
| Domain | - | 2.32e-03 | 333 | 130 | 8 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 2.41e-03 | 335 | 130 | 8 | IPR015943 | |
| Domain | WD40 | 2.74e-03 | 268 | 130 | 7 | SM00320 | |
| Domain | SET | 2.90e-03 | 41 | 130 | 3 | PF00856 | |
| Domain | WD40_repeat | 2.97e-03 | 272 | 130 | 7 | IPR001680 | |
| Domain | WD_REPEATS_2 | 3.42e-03 | 279 | 130 | 7 | PS50082 | |
| Domain | WD_REPEATS_REGION | 3.42e-03 | 279 | 130 | 7 | PS50294 | |
| Domain | SET | 4.02e-03 | 46 | 130 | 3 | SM00317 | |
| Domain | FERM_M | 4.02e-03 | 46 | 130 | 3 | PF00373 | |
| Domain | - | 4.81e-03 | 49 | 130 | 3 | 1.20.80.10 | |
| Domain | FERM_central | 4.81e-03 | 49 | 130 | 3 | IPR019748 | |
| Domain | FERM_domain | 4.81e-03 | 49 | 130 | 3 | IPR000299 | |
| Domain | SET_dom | 5.09e-03 | 50 | 130 | 3 | IPR001214 | |
| Domain | FERM/acyl-CoA-bd_prot_3-hlx | 5.09e-03 | 50 | 130 | 3 | IPR014352 | |
| Domain | FERM_1 | 5.09e-03 | 50 | 130 | 3 | PS00660 | |
| Domain | FERM_2 | 5.09e-03 | 50 | 130 | 3 | PS00661 | |
| Domain | SET | 5.09e-03 | 50 | 130 | 3 | PS50280 | |
| Domain | FERM_3 | 5.09e-03 | 50 | 130 | 3 | PS50057 | |
| Domain | Band_41_domain | 5.09e-03 | 50 | 130 | 3 | IPR019749 | |
| Domain | B41 | 5.09e-03 | 50 | 130 | 3 | SM00295 | |
| Domain | Post-SET_dom | 5.41e-03 | 16 | 130 | 2 | IPR003616 | |
| Domain | GATA_ZN_FINGER_1 | 5.41e-03 | 16 | 130 | 2 | PS00344 | |
| Domain | PostSET | 5.41e-03 | 16 | 130 | 2 | SM00508 | |
| Domain | GATA_ZN_FINGER_2 | 5.41e-03 | 16 | 130 | 2 | PS50114 | |
| Domain | POST_SET | 5.41e-03 | 16 | 130 | 2 | PS50868 | |
| Domain | - | 6.09e-03 | 391 | 130 | 8 | 2.30.29.30 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SOX4 SETD1A KIAA0513 MYO9B MYO10 DVL1 SMG5 HUWE1 LYST ARHGEF10L PPP1R26 DACT1 TNRC18 AATK KANSL1 TRAPPC12 KANK3 PPP1R15B SBF2 IFRD2 SCN5A CTDP1 NLGN2 SOWAHB IQCE BAHCC1 | 6.82e-14 | 1105 | 131 | 26 | 35748872 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | SDE2 ZMYND11 VRK3 ATRX BAZ2B DIDO1 CHD2 SSRP1 WDR76 JMJD1C ORC2 KAT7 SBNO1 CFDP1 TMPO BOP1 PHF14 BOD1L1 | 1.72e-11 | 608 | 131 | 18 | 36089195 |
| Pubmed | SDE2 ZMYND11 ATRX PHF23 CDKN2AIP DIDO1 CHD2 SSRP1 PAF1 KAT7 SRRT SETD2 UBR5 SBNO1 UBXN7 CFDP1 BOP1 PHF14 BOD1L1 EIF2AK2 CDCA7L | 2.35e-10 | 1014 | 131 | 21 | 32416067 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | CDK17 SNX24 NOC2L MYO10 CDKN2AIP DVL1 DVL3 SSRP1 PAF1 CEP43 SHQ1 GPALPP1 KAT7 SRRT SETD2 MRTFB UBR5 SBF2 ZC3H12C DBR1 AGTPBP1 | 3.59e-10 | 1038 | 131 | 21 | 26673895 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | HMBOX1 VRK3 ATRX BAZ2B NOC2L GPATCH1 DIDO1 CHD2 SSRP1 PAF1 WDR76 JMJD1C ORC2 KAT7 SRRT SETD2 KANSL1 NFXL1 TMPO PHF14 ASXL2 CDCA7L | 3.27e-09 | 1294 | 131 | 22 | 30804502 |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | SETD1A NOC2L GPATCH1 DIDO1 PAF1 JMJD1C ORC2 SRRT MRTFB SBNO1 UBXN7 EIF2AK2 | 7.27e-09 | 341 | 131 | 12 | 32971831 |
| Pubmed | ZMYND11 ATRX DVL3 HUWE1 PPP1R26 MRTFB KANSL1 UBR5 PPP1R15B PDE4DIP CFDP1 ASXL2 KIF13A SDK1 | 5.69e-08 | 591 | 131 | 14 | 15231748 | |
| Pubmed | FLG PHACTR2 ATRX NOC2L SKIDA1 CHD2 SSRP1 EPB41L3 LYST SFMBT2 GPALPP1 TNRC18 SBNO1 CCDC47 NFXL1 TMPO PHF14 BOD1L1 ATP1A2 MLPH BAHCC1 | 1.08e-07 | 1442 | 131 | 21 | 35575683 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | ATRX GPATCH1 DIDO1 SSRP1 JMJD1C ORC2 MRTFB CFDP1 TMPO BOD1L1 | 1.32e-07 | 283 | 131 | 10 | 30585729 |
| Pubmed | 2.08e-07 | 4 | 131 | 3 | 24643799 | ||
| Pubmed | BAZ2B EPB41L3 CLSTN1 JMJD1C GPALPP1 PPP1R26 SETD2 TNRC18 FIG4 SBF2 PHF14 NLGN2 | 3.98e-07 | 493 | 131 | 12 | 15368895 | |
| Pubmed | FRMPD4 KIAA0513 MYO10 KANSL1 UBR5 PDE4DIP FNIP1 BOD1L1 ASXL2 RERE AGTPBP1 | 4.45e-07 | 407 | 131 | 11 | 12693553 | |
| Pubmed | DVL1 DVL3 ZNF217 HUWE1 EPB41L3 JMJD1C SFMBT2 MRTFB UBR5 RERE PROX1 | 5.79e-07 | 418 | 131 | 11 | 34709266 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | ATRX BAZ2B CDKN2AIP GPATCH1 DIDO1 SSRP1 PAF1 EPB41L3 CWC22 JMJD1C ORC2 SRRT SETD2 TMPO PHF14 BOD1L1 | 6.61e-07 | 954 | 131 | 16 | 36373674 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | VRK3 KIAA0513 PHF23 MYO9B NOC2L SMG5 HUWE1 JMJD1C ORC2 KANSL1 UBR5 CFDP1 NFXL1 ASXL2 AGTPBP1 | 8.94e-07 | 857 | 131 | 15 | 25609649 |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | ATRX MYO9B NOC2L CHD2 SSRP1 CWC22 KAT7 BRDT KMT5B TMPO BOP1 PROX1 | 9.03e-07 | 533 | 131 | 12 | 30554943 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ATRX DIDO1 ZNF217 HUWE1 SSRP1 SRRT PACS1 SETD2 KANSL1 CTDP1 TMPO PHF14 RERE AGTPBP1 | 1.44e-06 | 774 | 131 | 14 | 15302935 |
| Pubmed | SETD1A ATRX NOC2L CHD2 HUWE1 SSRP1 ORC2 KAT7 PHF14 BOD1L1 CDCA7L | 1.77e-06 | 469 | 131 | 11 | 27634302 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | SETD1A VRK3 NOC2L CDKN2AIP DVL3 DIDO1 CHD2 HUWE1 SSRP1 PAF1 CWC22 GPALPP1 ORC2 CCDC47 IFRD2 TMPO BOP1 EIF2AK2 | 2.39e-06 | 1318 | 131 | 18 | 30463901 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | SDE2 ATRX CDKN2AIP GPATCH1 DIDO1 PAF1 EPB41L3 GPALPP1 ORC2 SETD2 MRTFB CFDP1 C1orf52 TMPO BOD1L1 | 2.57e-06 | 934 | 131 | 15 | 33916271 |
| Pubmed | SEL1L SOX4 KIF21B ATRX PHF23 MYO10 CDKN2AIP ZNF217 KAT7 SETD2 PTCHD1 UBR5 SBNO1 KMT5B PHLPP1 PHF14 RERE SOWAHB | 2.62e-06 | 1327 | 131 | 18 | 32694731 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 2.66e-06 | 394 | 131 | 10 | 27248496 | |
| Pubmed | 2.88e-06 | 8 | 131 | 3 | 17428193 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | HMBOX1 ATRX CHD2 WDR25 HUWE1 CEP43 JMJD1C SFMBT2 BRWD3 PACS1 TNRC18 MRTFB SBF2 FNIP1 PHF14 BOD1L1 NLGN2 RERE MLPH | 3.28e-06 | 1489 | 131 | 19 | 28611215 |
| Pubmed | 3.51e-06 | 167 | 131 | 7 | 25659891 | ||
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | NOC2L DIDO1 ZNF217 HUWE1 SSRP1 PAF1 CWC22 JMJD1C KAT7 SRRT TMPO BOP1 PHF14 BOD1L1 EIF2AK2 | 5.13e-06 | 989 | 131 | 15 | 36424410 |
| Pubmed | KIF21B SETD1A SDK2 DIDO1 SMG5 CWC22 ARHGEF10L UBXN7 BOP1 ATP1A2 IQCE | 5.58e-06 | 529 | 131 | 11 | 14621295 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 7.01e-06 | 440 | 131 | 10 | 34244565 | |
| Pubmed | SETD1A DVL1 DIDO1 HUWE1 SSRP1 PAF1 JMJD1C SETD2 MRTFB TMPO BOD1L1 | 7.91e-06 | 549 | 131 | 11 | 38280479 | |
| Pubmed | 8.43e-06 | 11 | 131 | 3 | 11483621 | ||
| Pubmed | 9.71e-06 | 195 | 131 | 7 | 19454010 | ||
| Pubmed | A family of 12 human genes containing oxysterol-binding domains. | 1.12e-05 | 12 | 131 | 3 | 11735225 | |
| Pubmed | An oxysterol-binding protein family identified in the mouse. | 1.12e-05 | 12 | 131 | 3 | 12215260 | |
| Pubmed | SOX4 HMBOX1 ZNF410 ZMYND11 PHF23 DIDO1 SSRP1 PAF1 KAT7 BRDT PKNOX1 PHF14 ZNF654 | 1.22e-05 | 808 | 131 | 13 | 20412781 | |
| Pubmed | Sulindac inhibits canonical Wnt signaling by blocking the PDZ domain of the protein Dishevelled. | 1.41e-05 | 2 | 131 | 2 | 19637179 | |
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 23325844 | ||
| Pubmed | BOD1L mediates chromatin binding and non-canonical function of H3K4 methyltransferase SETD1A. | 1.41e-05 | 2 | 131 | 2 | 38989615 | |
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 14636582 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 32555450 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 9344861 | ||
| Pubmed | Sidekick-1 is upregulated in glomeruli in HIV-associated nephropathy. | 1.41e-05 | 2 | 131 | 2 | 15213259 | |
| Pubmed | DVL1 and DVL3 require nuclear localisation to regulate proliferation in human myoblasts. | 1.41e-05 | 2 | 131 | 2 | 35589804 | |
| Pubmed | Epigenotype-genotype-phenotype correlations in SETD1A and SETD2 chromatin disorders. | 1.41e-05 | 2 | 131 | 2 | 37166351 | |
| Pubmed | Definition of the critical domains required for homophilic targeting of mouse sidekick molecules. | 1.41e-05 | 2 | 131 | 2 | 15703275 | |
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 30150416 | ||
| Pubmed | Sidekicks: synaptic adhesion molecules that promote lamina-specific connectivity in the retina. | 1.41e-05 | 2 | 131 | 2 | 12230981 | |
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 21763455 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 26924530 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 24040443 | ||
| Pubmed | Molecular basis of sidekick-mediated cell-cell adhesion and specificity. | 1.41e-05 | 2 | 131 | 2 | 27644106 | |
| Pubmed | FLG MYO9B DIDO1 SSRP1 PAF1 KAT7 CCDC47 SBF2 NFXL1 TMPO EIF2AK2 | 1.83e-05 | 601 | 131 | 11 | 33658012 | |
| Pubmed | DVL3 HUWE1 EPB41L3 SETD2 BRDT TMPO FNIP1 BOP1 EIF2AK2 AGTPBP1 | 1.97e-05 | 496 | 131 | 10 | 31343991 | |
| Pubmed | 2.12e-05 | 43 | 131 | 4 | 33472061 | ||
| Pubmed | A directed protein interaction network for investigating intracellular signal transduction. | KIF21B VRK3 SNX24 MYO9B DVL1 DVL3 ODC1 CEP43 JMJD1C KAT7 DACT1 PDE4DIP BOP1 OSBP2 PCDH8 | 2.31e-05 | 1124 | 131 | 15 | 21900206 |
| Pubmed | ATRX proximal protein associations boast roles beyond histone deposition. | 2.52e-05 | 91 | 131 | 5 | 34780483 | |
| Pubmed | Armc5 deletion causes developmental defects and compromises T-cell immune responses. | 3.42e-05 | 17 | 131 | 3 | 28169274 | |
| Pubmed | 3.96e-05 | 332 | 131 | 8 | 25693804 | ||
| Pubmed | 4.09e-05 | 18 | 131 | 3 | 19701191 | ||
| Pubmed | 4.16e-05 | 101 | 131 | 5 | 9872452 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 15748172 | ||
| Pubmed | Differential mediation of the Wnt canonical pathway by mammalian Dishevelleds-1, -2, and -3. | 4.21e-05 | 3 | 131 | 2 | 18093802 | |
| Pubmed | circ_JMJD1C expedites breast cancer progression by regulating miR-182-5p/JMJD1C/SOX4 axis. | 4.21e-05 | 3 | 131 | 2 | 38650133 | |
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 32900645 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 27744318 | ||
| Pubmed | Dishevelled proteins are significantly upregulated in chronic lymphocytic leukaemia. | 4.21e-05 | 3 | 131 | 2 | 27086035 | |
| Pubmed | Cytosolic TMEM88 promotes invasion and metastasis in lung cancer cells by binding DVLS. | 4.21e-05 | 3 | 131 | 2 | 26359454 | |
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 21092292 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 29749639 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 3910518 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 8973355 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 18692936 | ||
| Pubmed | SETD2 is essential for terminal differentiation of erythroblasts during fetal erythropoiesis. | 4.21e-05 | 3 | 131 | 2 | 33743353 | |
| Pubmed | Plk1 phosphorylation of orc2 and hbo1 contributes to gemcitabine resistance in pancreatic cancer. | 4.21e-05 | 3 | 131 | 2 | 23188630 | |
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 30042175 | ||
| Pubmed | Dishevelled proteins are associated with olfactory sensory neuron presynaptic terminals. | 4.21e-05 | 3 | 131 | 2 | 23437169 | |
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 25577943 | ||
| Pubmed | 4.31e-05 | 246 | 131 | 7 | 15345747 | ||
| Pubmed | 4.36e-05 | 102 | 131 | 5 | 11214970 | ||
| Pubmed | 4.57e-05 | 103 | 131 | 5 | 32744500 | ||
| Pubmed | 4.59e-05 | 339 | 131 | 8 | 30415952 | ||
| Pubmed | 4.89e-05 | 251 | 131 | 7 | 28077445 | ||
| Pubmed | SEL1L VRK3 ATRX NOC2L CDKN2AIP DIDO1 CHD2 ZNF217 SSRP1 SRRT SETD2 MRTFB CCDC47 IFRD2 BOP1 PHF14 EIF2AK2 | 4.93e-05 | 1497 | 131 | 17 | 31527615 | |
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | 5.63e-05 | 349 | 131 | 8 | 25665578 | |
| Pubmed | ZNF821 ATRX DIDO1 CHD2 HUWE1 KAT7 PACS1 SBF2 NFXL1 BOP1 BOD1L1 ASXL2 KIF13A STK24 | 6.24e-05 | 1084 | 131 | 14 | 11544199 | |
| Pubmed | 6.51e-05 | 57 | 131 | 4 | 18022353 | ||
| Pubmed | Genome-scale RNAi screen for host factors required for HIV replication. | 7.12e-05 | 361 | 131 | 8 | 18976975 | |
| Pubmed | 8.41e-05 | 4 | 131 | 2 | 8817329 | ||
| Pubmed | Human dishevelled genes constitute a DHR-containing multigene family. | 8.41e-05 | 4 | 131 | 2 | 9192851 | |
| Pubmed | Mutations in the LRRK2 Roc-COR tandem domain link Parkinson's disease to Wnt signalling pathways. | 8.41e-05 | 4 | 131 | 2 | 19625296 | |
| Pubmed | 8.41e-05 | 4 | 131 | 2 | 25043421 | ||
| Pubmed | Inhibition of the Wnt/beta-catenin pathway by the WWOX tumor suppressor protein. | 8.41e-05 | 4 | 131 | 2 | 19465938 | |
| Pubmed | Phosphorylation of Dishevelled by protein kinase RIPK4 regulates Wnt signaling. | 8.41e-05 | 4 | 131 | 2 | 23371553 | |
| Pubmed | Wnt3a-mediated formation of phosphatidylinositol 4,5-bisphosphate regulates LRP6 phosphorylation. | 8.41e-05 | 4 | 131 | 2 | 18772438 | |
| Pubmed | DCDC2 mutations cause a renal-hepatic ciliopathy by disrupting Wnt signaling. | 8.41e-05 | 4 | 131 | 2 | 25557784 | |
| Pubmed | Inhibition of the Wnt signaling pathway by Idax, a novel Dvl-binding protein. | 8.41e-05 | 4 | 131 | 2 | 11113207 | |
| Pubmed | Activation of p53 by Dishevelled independent of Wnt or planar polarity pathways. | 8.41e-05 | 4 | 131 | 2 | 17593335 | |
| Pubmed | 8.41e-05 | 4 | 131 | 2 | 24357716 | ||
| Pubmed | 8.41e-05 | 4 | 131 | 2 | 33496066 | ||
| Pubmed | ZMYND11 SSRP1 EPB41L3 BRWD3 KAT7 SETD2 BRDT UBR5 KMT5B SCN5A RERE AGTPBP1 BAHCC1 PROX1 | 8.49e-05 | 1116 | 131 | 14 | 31753913 | |
| Pubmed | UBXD7 binds multiple ubiquitin ligases and implicates p97 in HIF1alpha turnover. | 9.05e-05 | 62 | 131 | 4 | 18775313 | |
| Interaction | NUP43 interactions | SETD1A BAZ2B NOC2L CDKN2AIP GPATCH1 DVL1 SSRP1 PAF1 CWC22 JMJD1C GPALPP1 SRRT SETD2 MRTFB KANSL1 UBR5 TRAPPC12 UBXN7 BOP1 BOD1L1 ASXL2 RERE | 9.98e-11 | 625 | 131 | 22 | int:NUP43 |
| Interaction | H2BC21 interactions | VRK3 SPANXN2 ATRX NOC2L DIDO1 SMG5 HUWE1 SSRP1 PAF1 EPB41L3 WDR76 JMJD1C SFMBT2 ORC2 KAT7 MRTFB CFDP1 PHF14 CDCA7L BAHCC1 | 2.41e-08 | 696 | 131 | 20 | int:H2BC21 |
| Interaction | SYT2 interactions | SETD1A SMG5 PAF1 CWC22 TRMT10A AP3B2 UBXN7 CTDP1 C1orf52 BOP1 | 5.16e-08 | 150 | 131 | 10 | int:SYT2 |
| Interaction | CSNK2B interactions | ZNF410 VRK3 ATRX BAZ2B DIDO1 ODC1 SSRP1 PAF1 EPB41L3 WDR76 LYST KAT7 PACS1 DACT1 SETD2 BRDT CTDP1 TMPO | 1.25e-07 | 625 | 131 | 18 | int:CSNK2B |
| Interaction | TOP3B interactions | SOX4 SETD1A KIAA0513 MYO9B NOC2L MYO10 DVL1 SMG5 HUWE1 SSRP1 LYST ARHGEF10L PPP1R26 DACT1 TNRC18 AATK KANSL1 TRAPPC12 KANK3 PPP1R15B SBF2 IFRD2 SCN5A CTDP1 NLGN2 SOWAHB IQCE BAHCC1 | 2.04e-07 | 1470 | 131 | 28 | int:TOP3B |
| Interaction | H2BC8 interactions | SDE2 ATRX DIDO1 SSRP1 WDR76 GPALPP1 ORC2 KAT7 SBNO1 CCDC47 UBXN7 CFDP1 C1orf52 TMPO BOP1 PHF14 | 1.07e-06 | 576 | 131 | 16 | int:H2BC8 |
| Interaction | H3-3A interactions | SETD1A SDE2 ZMYND11 VRK3 ATRX DIDO1 CHD2 SSRP1 WDR76 JMJD1C BRWD3 ORC2 KAT7 SBNO1 CFDP1 TMPO PHF14 BOD1L1 | 1.73e-06 | 749 | 131 | 18 | int:H3-3A |
| Interaction | MEN1 interactions | SETD1A ATRX NOC2L GPATCH1 DIDO1 SSRP1 PAF1 JMJD1C ORC2 KAT7 SRRT MRTFB KANSL1 UBR5 SBNO1 UBXN7 BOP1 BOD1L1 RERE EIF2AK2 CDCA7L | 2.98e-06 | 1029 | 131 | 21 | int:MEN1 |
| Interaction | DPY30 interactions | 7.62e-06 | 204 | 131 | 9 | int:DPY30 | |
| Interaction | EPB41L3 interactions | SETD1A SPANXN2 ATRX HUWE1 EPB41L3 CWC22 TNRC18 AP3B2 BOD1L1 AGTPBP1 | 1.17e-05 | 272 | 131 | 10 | int:EPB41L3 |
| Interaction | CSNK2A1 interactions | FLG SETD1A ATRX DVL1 DVL3 ZNF217 SSRP1 PAF1 EPB41L3 LYST BRWD3 KAT7 SRRT PACS1 CFDP1 CTDP1 TMPO BOP1 ASXL2 | 1.35e-05 | 956 | 131 | 19 | int:CSNK2A1 |
| Interaction | POLR1G interactions | BAZ2B NOC2L EIF1AD CHD2 HUWE1 SSRP1 PAF1 KAT7 SBNO1 CFDP1 BOP1 PHF14 AGTPBP1 | 1.85e-05 | 489 | 131 | 13 | int:POLR1G |
| Interaction | H3C3 interactions | ATRX BAZ2B DIDO1 SSRP1 WDR76 JMJD1C ORC2 KAT7 SBNO1 TMPO BOP1 PHF14 BOD1L1 | 2.10e-05 | 495 | 131 | 13 | int:H3C3 |
| Interaction | H2AC4 interactions | SETD1A ATRX NOC2L CHD2 SSRP1 WDR76 PPP1R26 KAT7 UBR5 CFDP1 BOP1 PHF14 EIF2AK2 | 2.65e-05 | 506 | 131 | 13 | int:H2AC4 |
| Interaction | ATN1 interactions | 3.10e-05 | 187 | 131 | 8 | int:ATN1 | |
| Interaction | HDAC1 interactions | ZMYND11 ATRX PHF23 DVL1 DVL3 ZNF217 EPB41L3 WDR76 JMJD1C SRRT DACT1 TNRC18 MRTFB UBR5 CCDC47 PHLPP1 PHF14 RERE STK24 BAHCC1 | 3.13e-05 | 1108 | 131 | 20 | int:HDAC1 |
| Interaction | BEND7 interactions | 3.43e-05 | 94 | 131 | 6 | int:BEND7 | |
| Interaction | PPP1CA interactions | FRMPD4 VRK3 NOC2L HUWE1 SSRP1 PPP1R26 PACS1 AATK UBR5 PPP1R15B CTDP1 TMPO KIF13A EIF2AK2 STK24 | 4.76e-05 | 696 | 131 | 15 | int:PPP1CA |
| Interaction | SNRNP40 interactions | BAZ2B CDKN2AIP GPATCH1 DVL1 ZNF217 SSRP1 PAF1 CWC22 GPALPP1 SRRT SETD2 UBR5 UBXN7 BOP1 | 7.02e-05 | 637 | 131 | 14 | int:SNRNP40 |
| Interaction | NUCKS1 interactions | 9.72e-05 | 220 | 131 | 8 | int:NUCKS1 | |
| Interaction | CCDC71 interactions | 1.06e-04 | 72 | 131 | 5 | int:CCDC71 | |
| Interaction | XRCC6 interactions | VRK3 ATRX CDKN2AIP GPATCH1 DVL3 DIDO1 HUWE1 SSRP1 WDR76 JMJD1C ORC2 TNRC18 MRTFB CFDP1 TMPO BOD1L1 ASXL2 | 1.09e-04 | 928 | 131 | 17 | int:XRCC6 |
| Interaction | MCM6 interactions | 1.10e-04 | 287 | 131 | 9 | int:MCM6 | |
| Interaction | RBBP5 interactions | 1.10e-04 | 287 | 131 | 9 | int:RBBP5 | |
| Interaction | ZNF821 interactions | 1.15e-04 | 15 | 131 | 3 | int:ZNF821 | |
| Interaction | PYHIN1 interactions | 1.19e-04 | 358 | 131 | 10 | int:PYHIN1 | |
| Interaction | NLE1 interactions | 1.24e-04 | 228 | 131 | 8 | int:NLE1 | |
| Interaction | FGF11 interactions | 1.25e-04 | 170 | 131 | 7 | int:FGF11 | |
| Interaction | SULF2 interactions | 1.28e-04 | 119 | 131 | 6 | int:SULF2 | |
| Interaction | HCFC1 interactions | 1.29e-04 | 293 | 131 | 9 | int:HCFC1 | |
| Interaction | VAX1 interactions | 1.41e-04 | 16 | 131 | 3 | int:VAX1 | |
| Interaction | SSRP1 interactions | ATRX DIDO1 CHD2 HUWE1 SSRP1 PAF1 WDR76 BRWD3 KAT7 SRRT SETD2 UBR5 SBNO1 PHF14 | 1.51e-04 | 685 | 131 | 14 | int:SSRP1 |
| Interaction | CT45A5 interactions | 1.55e-04 | 78 | 131 | 5 | int:CT45A5 | |
| Interaction | H2BC9 interactions | PHACTR2 ATRX BAZ2B SSRP1 CEP43 SFMBT2 TNRC18 SBNO1 PDE4DIP CFDP1 TMPO | 1.62e-04 | 446 | 131 | 11 | int:H2BC9 |
| Interaction | DDB1 interactions | SETD1A DCAF8L2 HUWE1 SSRP1 PAF1 EPB41L3 WDR76 CEP43 BRWD3 SRRT SETD2 UBR5 UBXN7 ASXL2 | 1.80e-04 | 697 | 131 | 14 | int:DDB1 |
| Interaction | H2BC11 interactions | 2.17e-04 | 186 | 131 | 7 | int:H2BC11 | |
| Interaction | CSNK2A2 interactions | ATRX EIF1AD HUWE1 SSRP1 PAF1 EPB41L3 LYST BRWD3 BRDT UBXN7 CFDP1 CTDP1 BOP1 PHF14 | 2.44e-04 | 718 | 131 | 14 | int:CSNK2A2 |
| Interaction | FGF12 interactions | 2.59e-04 | 87 | 131 | 5 | int:FGF12 | |
| Interaction | TERF2IP interactions | SETD1A SDE2 DIDO1 SSRP1 PAF1 SETD2 SBNO1 UBXN7 CFDP1 C1orf52 BOD1L1 STK24 | 2.61e-04 | 552 | 131 | 12 | int:TERF2IP |
| Interaction | DDX23 interactions | NOC2L CHD2 SSRP1 PAF1 CWC22 GPALPP1 SETD2 BRDT UBR5 BOP1 STK24 | 3.04e-04 | 480 | 131 | 11 | int:DDX23 |
| Interaction | CBX3 interactions | SETD1A ATRX ZNF217 SSRP1 WDR76 ORC2 SRRT SETD2 SBNO1 UBXN7 CFDP1 C1orf52 ASXL2 | 3.04e-04 | 646 | 131 | 13 | int:CBX3 |
| Interaction | H2AC19 interactions | 3.12e-04 | 50 | 131 | 4 | int:H2AC19 | |
| Interaction | HCFC2 interactions | 3.36e-04 | 92 | 131 | 5 | int:HCFC2 | |
| Interaction | UHRF2 interactions | 3.38e-04 | 200 | 131 | 7 | int:UHRF2 | |
| Interaction | NFKBIL1 interactions | 3.53e-04 | 93 | 131 | 5 | int:NFKBIL1 | |
| Interaction | ATRX interactions | 3.63e-04 | 267 | 131 | 8 | int:ATRX | |
| Interaction | MCM7 interactions | SETD1A ATRX HUWE1 SSRP1 WDR76 ARHGEF10L ORC2 SRRT TMPO STK24 | 3.81e-04 | 414 | 131 | 10 | int:MCM7 |
| Interaction | KAT8 interactions | 3.90e-04 | 95 | 131 | 5 | int:KAT8 | |
| GeneFamily | Oxysterol binding proteins|Pleckstrin homology domain containing | 1.92e-05 | 12 | 82 | 3 | 670 | |
| GeneFamily | PHD finger proteins | 5.51e-05 | 90 | 82 | 5 | 88 | |
| GeneFamily | Dishevelled segment polarity proteins|PDZ domain containing | 1.21e-04 | 4 | 82 | 2 | 505 | |
| GeneFamily | WD repeat domain containing | 1.87e-04 | 262 | 82 | 7 | 362 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 4.86e-04 | 34 | 82 | 3 | 487 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 7.17e-04 | 9 | 82 | 2 | 1203 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.39e-03 | 181 | 82 | 5 | 694 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 1.51e-03 | 50 | 82 | 3 | 1293 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.45e-03 | 206 | 82 | 5 | 682 | |
| GeneFamily | Cadherin related | 2.64e-03 | 17 | 82 | 2 | 24 | |
| GeneFamily | Guanylate cyclase receptors|DENN/MADD domain containing | 5.70e-03 | 25 | 82 | 2 | 504 | |
| Coexpression | GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_TREG_CD4_TCELL_UP | DVL3 ODC1 SFMBT2 TRMT10A SBF2 CFDP1 PHLPP1 KIF13A STK24 IQCE | 1.30e-08 | 169 | 130 | 10 | M8940 |
| Coexpression | GSE27786_LIN_NEG_VS_BCELL_DN | 7.27e-07 | 200 | 130 | 9 | M4768 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | KIF21B CDK17 ATRX MYO9B CHD2 ZNF217 ODC1 HUWE1 LYST JMJD1C SFMBT2 IFNAR2 PACS1 SETD2 KANSL1 UBR5 SBNO1 PPP1R15B PDE4DIP BOD1L1 ASXL2 STK24 | 4.12e-06 | 1492 | 130 | 22 | M40023 |
| Coexpression | GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_IL12_CD8_TCELL_UP | 7.06e-06 | 199 | 130 | 8 | M3599 | |
| Coexpression | GSE39820_CTRL_VS_TGFBETA1_IL6_IL23A_CD4_TCELL_UP | 7.06e-06 | 199 | 130 | 8 | M5607 | |
| Coexpression | GSE17721_POLYIC_VS_GARDIQUIMOD_16H_BMDC_UP | 7.32e-06 | 200 | 130 | 8 | M4031 | |
| Coexpression | VERHAAK_GLIOBLASTOMA_PRONEURAL | 2.99e-05 | 177 | 130 | 7 | M2115 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 3.33e-05 | 180 | 130 | 7 | M8239 | |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | SOX4 SDE2 SDK2 MYO9B CHD2 ZNF217 ODC1 SFMBT2 PACS1 OSBPL2 SBF2 PDE4DIP RERE STK24 SDK1 PROX1 | 4.11e-05 | 1009 | 130 | 16 | M157 |
| Coexpression | GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_A3R_INH_AND_TCELL_MEMBRANES_ACT_MAST_CELL_UP | 5.35e-05 | 194 | 130 | 7 | M7313 | |
| Coexpression | GSE17721_LPS_VS_GARDIQUIMOD_12H_BMDC_UP | 6.29e-05 | 199 | 130 | 7 | M4058 | |
| Coexpression | GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_DN | 6.49e-05 | 200 | 130 | 7 | M5073 | |
| Coexpression | GSE37534_GW1929_VS_PIOGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_DN | 6.49e-05 | 200 | 130 | 7 | M8986 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_1H_UP | 6.49e-05 | 200 | 130 | 7 | M9926 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 1.14e-04 | 466 | 130 | 10 | M13522 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | KIF21B FRMPD4 ATRX LYST PNMA8B PACS1 DACT1 AATK SBF2 SCN3A AP3B2 PDE4DIP BOD1L1 KIF13A PCDH8 AGTPBP1 | 1.20e-04 | 1106 | 130 | 16 | M39071 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 1.30e-04 | 300 | 130 | 8 | M8702 | |
| Coexpression | GSE4590_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_DN | 1.36e-04 | 157 | 130 | 6 | M6871 | |
| Coexpression | HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_POSITIVE | SEL1L SOX4 KIAA0513 MYO9B BAZ2B DVL3 LYST JMJD1C BRWD3 TNRC18 CCDC47 PPP1R15B SBF2 BOP1 ZC3H12C KIF13A BAHCC1 | 1.53e-04 | 1250 | 130 | 17 | M41099 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_1000 | SETD1A SDK2 TM9SF1 DIDO1 CHD2 JMJD1C PNMA8B IFNAR2 KAT7 TNRC18 KANSL1 | 1.44e-06 | 284 | 130 | 11 | gudmap_developingGonad_e16.5_epididymis_1000_k2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | HMBOX1 ATRX DIDO1 CHD2 SSRP1 PAF1 WDR76 ADCYAP1R1 SHQ1 TMPO BOD1L1 ASXL2 STK24 SDK1 ZNF654 | 3.75e-06 | 595 | 130 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.17e-05 | 259 | 130 | 9 | gudmap_developingGonad_e12.5_epididymis_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000 | 5.05e-05 | 275 | 130 | 9 | gudmap_developingGonad_e14.5_ epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | SETD1A ATRX CHD2 HUWE1 JMJD1C PNMA8B TRMT10A KANSL1 BRDT SBNO1 KANK3 NFXL1 FNIP1 ASXL2 GPAT2 | 8.26e-05 | 776 | 130 | 15 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | SOX4 SETD1A SDK2 ATRX TM9SF1 DIDO1 CHD2 JMJD1C PNMA8B IFNAR2 KAT7 TNRC18 KANSL1 FNIP1 ATP1A2 | 1.01e-04 | 790 | 130 | 15 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | SOX4 SETD1A ATRX MYO10 TM9SF1 DIDO1 CHD2 PNMA8B KAT7 TNRC18 KANSL1 BRDT SBNO1 FNIP1 GPAT2 | 1.26e-04 | 806 | 130 | 15 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | SOX4 MYO10 EPB41L3 KANSL1 SBNO1 UBXN7 ERCC6L2 ASXL2 KIF13A AGTPBP1 | 1.32e-04 | 385 | 130 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | ATRX MYO10 CHD2 HUWE1 ADCYAP1R1 SETD2 MRTFB UBR5 ERCC6L2 FNIP1 PHF14 BOD1L1 ZC3H12C RERE AGTPBP1 | 1.75e-04 | 831 | 130 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_500 | 2.43e-04 | 201 | 130 | 7 | gudmap_developingKidney_e15.5_500_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.43e-04 | 91 | 130 | 5 | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k3_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.82e-04 | 146 | 130 | 6 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000_k5 | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 9.59e-07 | 177 | 131 | 7 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 1.20e-06 | 183 | 131 | 7 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-HSC/MPP_and_pro-ELP|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.65e-06 | 192 | 131 | 7 | 38ec82aa2ec4f2c0a843e83f7fe54f6b2483ca3d | |
| ToppCell | Control-Endothelial-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.71e-06 | 193 | 131 | 7 | aff0649c73c634bc6ff0dc7759b4693a9236bf05 | |
| ToppCell | Control-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.71e-06 | 193 | 131 | 7 | c5f9fe03e64c211d4bcd4959e5b32f14841e336a | |
| ToppCell | Control-Endothelial-Endothelial-Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.71e-06 | 193 | 131 | 7 | e1d546165dcc2392f540162206852c4717d7306f | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-06 | 195 | 131 | 7 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.16e-06 | 200 | 131 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Stem_cells-ectodermal/neuroectodermal-like_cells|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 4.69e-06 | 83 | 131 | 5 | 6782bfb4d1391949cb001f96fd9c9585392722a6 | |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | 1.37e-05 | 176 | 131 | 6 | 3de0c7d77210049e5616db21eed1490a17a5ec2d | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-05 | 177 | 131 | 6 | 26bad614560609d318bfc9c235a698bca4e1c22c | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-05 | 177 | 131 | 6 | 426a9845df7fd13b02e744532c336c60bc4d4a22 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.42e-05 | 177 | 131 | 6 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-05 | 180 | 131 | 6 | 9db9899ca42455310e9b63df523fe6c4780abfb7 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 1.61e-05 | 181 | 131 | 6 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.88e-05 | 186 | 131 | 6 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-HSC/MPP_and_pro-ELP|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.05e-05 | 189 | 131 | 6 | af391c321753743709e2da01a5aa7782d8cc54e3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 2.11e-05 | 190 | 131 | 6 | f1363f7806cfc4f14fbc1b0e8dac2de813a88eee | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.31e-05 | 193 | 131 | 6 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | nucseq-Immune-Immune_Myeloid-pMON-pMON|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.38e-05 | 194 | 131 | 6 | e237384b02be460d44eeada3026a5691c66f6fc1 | |
| ToppCell | nucseq-Immune-Immune_Myeloid-pMON|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.38e-05 | 194 | 131 | 6 | 0bc83ae79873a5e473e6e1e3111924cd003986a1 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.45e-05 | 195 | 131 | 6 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster | 2.67e-05 | 198 | 131 | 6 | de5214a85fe017eb23d4aa8af624464f062ec57e | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.74e-05 | 199 | 131 | 6 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 3.06e-05 | 122 | 131 | 5 | a2f343962069253a08faa80fd70723b8488a99ec | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c05-FOS|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.31e-05 | 142 | 131 | 5 | ae495c8dd733f0fde66bddc281606543f21c0d4b | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2-17-52|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.20e-05 | 146 | 131 | 5 | 26493014daa432db721613ef480d133f3da9eb58 | |
| Disease | Intellectual Disability | SOX4 SETD1A ZMYND11 FRMPD4 ODC1 BRWD3 PACS1 SETD2 PTCHD1 KANSL1 CCDC47 SCN3A | 7.25e-07 | 447 | 130 | 12 | C3714756 |
| Disease | Adenoid Cystic Carcinoma | 8.27e-05 | 100 | 130 | 5 | C0010606 | |
| Disease | Robinow Syndrome | 1.15e-04 | 4 | 130 | 2 | C0265205 | |
| Disease | Robinow Syndrome, Autosomal Dominant | 1.15e-04 | 4 | 130 | 2 | C4551476 | |
| Disease | brain measurement, neuroimaging measurement | KIF21B DCHS2 SNX24 CDKN2AIP GPATCH1 SKIDA1 DACT1 KANSL1 SBNO1 BAHCC1 | 1.69e-04 | 550 | 130 | 10 | EFO_0004346, EFO_0004464 |
| Disease | Mental Retardation, X-Linked | 2.81e-04 | 29 | 130 | 3 | C1136249 | |
| Disease | Global developmental delay | 3.15e-04 | 133 | 130 | 5 | C0557874 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 8.47e-04 | 10 | 130 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 8.47e-04 | 10 | 130 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | Macrocephaly | 1.03e-03 | 11 | 130 | 2 | C0221355 | |
| Disease | rotator cuff tear, shoulder impingement syndrome | 1.24e-03 | 12 | 130 | 2 | EFO_1001178, EFO_1001250 | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 1.24e-03 | 12 | 130 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | Dupuytren Contracture | 1.35e-03 | 108 | 130 | 4 | EFO_0004229 | |
| Disease | IGFBP-1 measurement | 1.46e-03 | 13 | 130 | 2 | EFO_0005118 | |
| Disease | Mental Retardation, X-Linked Nonsyndromic | 1.46e-03 | 13 | 130 | 2 | C3501611 | |
| Disease | Charcot-Marie-Tooth disease type 4 | 1.46e-03 | 13 | 130 | 2 | cv:C4082197 | |
| Disease | dystonia (is_implicated_in) | 1.69e-03 | 14 | 130 | 2 | DOID:543 (is_implicated_in) | |
| Disease | lymphocyte count | SEL1L PHF23 ZNF217 CLSTN1 LYST JMJD1C GPALPP1 SETD2 OSBPL2 SBNO1 EVA1A OSBPL7 ERCC6L2 PHLPP1 RERE | 2.02e-03 | 1464 | 130 | 15 | EFO_0004587 |
| Disease | obesity (implicated_via_orthology) | 2.69e-03 | 215 | 130 | 5 | DOID:9970 (implicated_via_orthology) | |
| Disease | glucose homeostasis measurement, acute insulin response measurement | 2.81e-03 | 18 | 130 | 2 | EFO_0006831, EFO_0006896 | |
| Disease | food allergy measurement, parental genotype effect measurement | 2.81e-03 | 18 | 130 | 2 | EFO_0005939, EFO_0007016 | |
| Disease | neuroticism measurement, wellbeing measurement, depressive symptom measurement | 3.14e-03 | 19 | 130 | 2 | EFO_0007006, EFO_0007660, EFO_0007869 | |
| Disease | venous thromboembolism, fibrinogen measurement | 3.26e-03 | 67 | 130 | 3 | EFO_0004286, EFO_0004623 | |
| Disease | alcohol consumption measurement | SETD1A WDR76 DACT1 TRMT10A KANSL1 BRDT CFDP1 ASXL2 RERE STK24 SDK1 IQCE BAHCC1 | 3.36e-03 | 1242 | 130 | 13 | EFO_0007878 |
| Disease | schizophrenia (implicated_via_orthology) | 3.40e-03 | 68 | 130 | 3 | DOID:5419 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EESVFSGLEDSGSDS | 56 | Q14137 | |
| TGTDLDFDLSSDSES | 446 | Q9Y5B0 | |
| DSDCHSSFSDEDEDG | 2316 | Q9P281 | |
| SSEFESYSEDSGEEA | 171 | Q9HCE6 | |
| SSEGNSSDDSEDERV | 406 | Q58F21 | |
| SSEGISSSDSDDLEE | 256 | Q9UIF8 | |
| DSNSESDTEGSEEED | 636 | Q9UIF8 | |
| DSSSEEDETVGTSDA | 821 | Q6RI45 | |
| TSAESESSEEEEGEQ | 946 | O94985 | |
| VSQDSDSEGHSEDSE | 946 | P20930 | |
| ASDSEGHSEESDTQS | 1071 | P20930 | |
| DSEGHSEESDTQSVS | 1721 | P20930 | |
| DSEGHSEDSDTQSVS | 2046 | P20930 | |
| SSVSQDSDSEGHSED | 2241 | P20930 | |
| SQASDSEGHSEDSDT | 2366 | P20930 | |
| VSQDSDSEGHSEDSE | 2891 | P20930 | |
| SDSEGHSEESDTQSV | 3341 | P20930 | |
| DSEGHSEDSDTQSVS | 3666 | P20930 | |
| GSSSSGSSDEEDNIE | 16 | Q8N6N3 | |
| SSELETTSFFDSDED | 181 | Q92997 | |
| GVETEDDEDTESNSS | 596 | Q9UPW5 | |
| EGSEESSDGQSDSQS | 96 | Q76L83 | |
| SGESSSESDNEDQDE | 711 | Q13367 | |
| DFSEIDDSDNFSDSA | 31 | Q96DM1 | |
| SSDSEDGSEDTVSDL | 81 | Q9H8M9 | |
| GFSSASSFDESEDDV | 356 | Q96DU7 | |
| DTGDDSLSAVTFDSD | 11 | Q6IPM2 | |
| GASESETTESADSEN | 41 | O60268 | |
| SSDGTEDSDFSTDLE | 11 | O95251 | |
| DSSTSDHFEEGNDDV | 866 | Q9P2G4 | |
| VEEQFSSSSEEGDED | 101 | Q6ZNB6 | |
| SSSSEEGDEDFEGKQ | 106 | Q6ZNB6 | |
| SYDTESGFEDSENTD | 796 | Q86WG5 | |
| DSTHSNEFDSDVDVG | 396 | P16233 | |
| SGEESSSEDDSDLFV | 131 | Q8N9N8 | |
| YEEESTDDSSSSEGD | 821 | Q4FZB7 | |
| TYESGSESGDSDESE | 1621 | Q15652 | |
| TDSNTDQDAGSSEED | 411 | Q9HCG8 | |
| GAASASTDEAADAES | 51 | Q9NXV6 | |
| AEFPDEESDESSSTS | 601 | P0C7V8 | |
| SDESGTSDQDEEDFQ | 216 | Q9H3M9 | |
| DFEDADTQEGDTESE | 81 | Q96A33 | |
| DVDGNDYSEQDDSTS | 366 | Q6NT76 | |
| SSSSEDEQGDSEDDQ | 766 | Q9BRR8 | |
| DSDFNDSDSDISGDA | 921 | O95206 | |
| TDEEISEFSEGSFSQ | 1106 | O75037 | |
| QGDFSFDEDSSDALS | 171 | Q9ULH7 | |
| FSSEGAQSSFEDSEE | 1136 | Q9HD67 | |
| AQSSFEDSEEDFDSR | 1141 | Q9HD67 | |
| QAFDSDVTDSSSGGE | 396 | Q7Z3B3 | |
| ADDEDSLTSEDSFFS | 281 | Q7L4E1 | |
| GSNDSDRYSDNEEDS | 176 | P42167 | |
| DTDSETEDFAGFTQS | 76 | Q96GN5 | |
| DGESDQASGTSSDEV | 106 | Q00537 | |
| GESSESFSASEDEGH | 421 | O75167 | |
| TQEEDSSGSNEDEDD | 2416 | Q7Z6Z7 | |
| SSGSNEDEDDSQDEE | 2421 | Q7Z6Z7 | |
| ASGFDSESESESENS | 21 | Q9Y3T9 | |
| NTHSDDSGDDDEATT | 281 | Q969R2 | |
| SDDSDFKVGDASDSE | 26 | O94880 | |
| ETETIGESDFGDSNS | 91 | P41586 | |
| EEESFSSEQEGSDDP | 281 | Q6VY07 | |
| SEDAPSDQSDTSESD | 491 | P48551 | |
| SDQSDTSESDVDLGD | 496 | P48551 | |
| QEGSGFFLSEDSDDS | 96 | Q6V1P9 | |
| AQEDGSEAAASDSSE | 511 | Q8N7H5 | |
| DSSEGFAISSESEEN | 1811 | Q8NFC6 | |
| HEADTTEDQSGATFD | 396 | P50993 | |
| SEDSEDSDFQESGVS | 1376 | P46100 | |
| EDANSESEGSSSEEE | 76 | Q9UEE9 | |
| DSESSVSEGEFVGES | 756 | Q9NYF0 | |
| TGEDDDYVDDFNSTS | 331 | O95684 | |
| ESSSEGDFSADTSEI | 201 | P19525 | |
| EEASGSDSGSQSESE | 26 | O14647 | |
| EEAVSSSSEDDSGTD | 751 | Q92562 | |
| DSSDEEDSQSQAASF | 816 | Q14CM0 | |
| NESSDSALGDSESED | 936 | Q8TF40 | |
| SGDFTDSDSDDFGEA | 656 | Q6NUI2 | |
| SSDSDEDSSSLYEEG | 46 | Q8IXQ4 | |
| DAETASEGSVESASE | 106 | Q9BTC0 | |
| SSVDGEDSTDDSYDE | 186 | Q6UXB0 | |
| NDSEDTSGYDSTASE | 921 | Q99698 | |
| ADSGSSDDEAASEAR | 91 | Q12894 | |
| EYESSSSEDASDSDG | 476 | Q6NY19 | |
| DSGEDQSEYNTDTSA | 406 | Q9UK59 | |
| LESSSFVDSDEDGST | 186 | O14640 | |
| AVEDSDGNTASDDES | 816 | Q5T890 | |
| ETAEGSNSESSDDDS | 221 | Q6IQ49 | |
| TNDIGDSDFSSETEA | 1556 | Q7Z5N4 | |
| DIGDSEFSEESESLT | 1481 | Q58EX2 | |
| DDSGSESDASDNEES | 731 | A3KN83 | |
| VEDSAESEDGVSASA | 391 | Q8NFZ4 | |
| TGSDDEDESSEQTFM | 301 | P11926 | |
| DTAADGETTATESDQ | 696 | Q9Y2J2 | |
| SVHDFDFEGDSDDST | 191 | Q9BV36 | |
| GADFSGDESEESSTQ | 126 | A6NGG8 | |
| LSASSSENEGSEEEE | 411 | Q9BZF2 | |
| SENEGSEEEESCTSE | 416 | Q9BZF2 | |
| DDSSENSSESGSLEV | 841 | Q9H1H9 | |
| SEYSASNSEDDEGVA | 181 | Q13416 | |
| SSGSSSSDDEFEDDL | 391 | Q06945 | |
| DSDLSEGFESDSSHD | 471 | Q9UPR3 | |
| NSFGDDEELSTSSDS | 176 | Q17RD7 | |
| ASSDEEGSQDESLDS | 21 | Q9UBV2 | |
| ATADQDDDSDGSTAA | 556 | Q6ZMQ8 | |
| SEGTTSASFDVDIEN | 81 | P55347 | |
| AGQSEDESVDSTEED | 401 | P55347 | |
| SSEDSDAETDGQASG | 316 | Q9Y6E0 | |
| SEDTAEGEEANTYES | 466 | Q96NR3 | |
| TSESDSQESGDQETE | 311 | Q9ULN7 | |
| YDSTDSENDEDGNLS | 261 | Q92786 | |
| SGASDSSEVSSEEED | 431 | Q1XH10 | |
| ADFADDENSTAGESE | 541 | Q14524 | |
| DSEDSDSSVSSGNED | 456 | Q6PI26 | |
| ASEASDSSSDDGIEE | 356 | Q5T8A7 | |
| LGSDASDFSDTSTED | 1186 | Q5T8A7 | |
| DVGSENDFADDEHST | 586 | Q9NY46 | |
| ESSDSRSVNDEGSSD | 686 | Q9P2R6 | |
| EAEDDGFDSDSSLSD | 451 | Q5SWA1 | |
| GFDSDSSLSDSDLEQ | 456 | Q5SWA1 | |
| LDSEGEEASQESSSE | 961 | O15047 | |
| TEVSDGEDEESDSSS | 1001 | O15047 | |
| ADSDGENDSTSDSES | 1021 | O15047 | |
| DFVDQESDGSEESSS | 396 | A6NEL2 | |
| VTGFDSDNSSGEFSE | 11 | Q9H1P3 | |
| NANDSSDDSGEETDE | 466 | Q08945 | |
| HSGDDSFDEGSVSES | 356 | Q9BXP5 | |
| SFDEGSVSESESESE | 361 | Q9BXP5 | |
| SVSESESESESGQAE | 366 | Q9BXP5 | |
| SSFSDSSEESFDQDE | 1811 | O15417 | |
| AESCGSFDETESEES | 111 | Q9Y343 | |
| DEFGSEENETASEGS | 41 | Q8WVT3 | |
| EDSGNDFLSSESTDS | 146 | Q86VK4 | |
| SAEGSSQEDEDLDSS | 91 | Q5MJ10 | |
| DSSEGSSQEDEDLDS | 116 | Q5MJ10 | |
| SSQEDEDLDSSEGSS | 121 | Q5MJ10 | |
| SSAVDFTAGSGEESE | 706 | Q5VUG0 | |
| DEGFDSLTDQSTGET | 496 | Q8IZM8 | |
| LFSDGDSSESEDTLS | 76 | Q8IV63 | |
| TETSQDGDASSSEGE | 306 | Q9BUL5 | |
| EDYSGSSESSNDESD | 1036 | Q9BYW2 | |
| GEEEAESSISSTSNE | 371 | Q15326 | |
| VDVESSQDGDSDEDT | 136 | Q9H967 | |
| DSRSDEESESELFSG | 311 | O94888 | |
| SGQEGSTDNDDSSSE | 316 | O75362 | |
| QDSSSSDSEGDEEET | 51 | O75541 | |
| FSSAFSDNGLDSDDE | 1536 | O60346 | |
| GSDSDSSEEEYSRNE | 301 | Q8TBZ6 | |
| SSGDSEENTNSDHES | 86 | Q9C0D7 | |
| DDSDSEAETEHAGSF | 16 | Q64LD2 | |
| DEETTSAGSGDDFDQ | 271 | O15321 | |
| FSEDDSQSNDSSDSD | 1661 | O95071 | |
| GSDEENLDSETSAST | 1991 | Q13459 | |
| AAGDDTEDTSTEFTD | 941 | Q5VU43 |